Sentences with phrase «human papillomavirus in»

They confirmed the presence of human papillomavirus in cervical cancer and also hepatitis virus B in hepatocellular (liver) cancer.

(Bosch FX, et al., «Prevalence of human papillomavirus in cervical cancer: A worldwide perspective,» J. Natl. Cancer Inst.

Poor Maria also harbored human papillomavirus in a venereal wart — the first diagnosis of this sexually transmitted, cancer - causing disease in the tissue of a mummy, Fornaciari reported in a 2006 paper.

Not exact matches

Kuo, H.K and Fujise, K. Human papillomavirus and cardiovascular disease among U.S. women in the National Health and Nutrition Examination Survey 2003 and 2006.

In terms of infection she still has to worry just as much if she was having sex with a boy; about contracting Herpes, Chlamydia, Gonorrhea or HPV, Human Papillomavirus.

In Canada, vaccines prevent illnesses such as diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type B (Hib), rotavirus, hepatitis B, measles, mumps, rubella, chickenpox, pneumococcal and meningococcal diseases, and human papillomavirus virus (HPV).

«Every government initiative, including the HPV [Human papillomavirus] vaccine, will increase [teenage infertility], but as all the targets revolve around pregnancy, no - one in power knows how many young people they are making sterile and nobody cares», it read.

Affecting sexually active women, in 99.7 % of all cases cervical cancer results from a history of infection by a group of viruses called human papillomavirus - or HPV.

Starting at age 21, women should be screened regularly for cervical cancer with a Pap test and possibly in combination with an HPV (human papillomavirus).

In all environments and independent of the resource settings, two doses of human papillomavirus vaccine are recommended for girls ages 9 to 14 years, with an interval of at least 6 months and up to 12 to 15 months between doses.

The new 9 - valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11 - or 12 - year - old children before they are exposed to the virus.

Today's guidance, written by a group of cervical cancer screening experts led by University of Alabama at Birmingham gynecologic oncologist Warner Huh, M.D., is being published simultaneously in the journals Gynecologic Oncology, Obstetrics & Gynecology, and the Journal of Lower Genital Tract Disease under the title «Use of Primary High Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance.»

But sometimes the arrangement turns contentious, as when blood - sucking bedbugs, fleas, and lice invade, or when herpes simplex or human papillomaviruses cause surface membranes to erupt in nasty pustules or warts.

In addition to protecting against 80 percent of cervical cancers, the new 9 - Valent human papillomavirus vaccine, which includes seven cancer causing HPV - types, has the potential to protect against nearly 19,000 other cancers diagnosed in the United States, including anal, oropharyngeal and penile cancerIn addition to protecting against 80 percent of cervical cancers, the new 9 - Valent human papillomavirus vaccine, which includes seven cancer causing HPV - types, has the potential to protect against nearly 19,000 other cancers diagnosed in the United States, including anal, oropharyngeal and penile cancerin the United States, including anal, oropharyngeal and penile cancers.

Human papillomavirus 16 accounts for about half of all cervical cancers, but researchers reporting September 7 in the journal Cell have found that not all infections are equal.

While nivolumab improved survival rates in the overall study population, it appeared to be most successful in patients whose tumors were positive for the human papillomavirus (HPV).

Since 2008, girls in the UK have been vaccinated against the human papillomavirus, which can cause cervical cancer.

The only VLP - based vaccine to hit the U.S. market is Merck & Co.'s Gardasil, which won FDA approval in June as preventative against certain types of human papillomavirus (HPV), which could lead to cervical cancer.

Alarmed by «pseudoscience» that may bring «devastating» health consequences, two groups of researchers have asked the journal Scientific Reports to retract a paper that they claim undermines confidence in the human papillomavirus (HPV) vaccine, given to girls to prevent cervical cancer.

The FDA approved Merck's Gardasil vaccine in 2006, after clinical trials showed that it protects against four strains of human papillomavirus (HPV), which together cause about 70 percent of cervical cancers and 90 percent of genital warts.

After claims arose that the human papillomavirus vaccine could cause debilitating side effects, the vaccine rate among women in Japan plummeted.

Oral human papillomavirus (HPV) infections were more common among men who had female partners with oral and / or genital HPV infection, suggesting that the transmission of HPV occurs via oral - oral and oral - genital routes, according to a McGill University study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

In contrast, viruses that cause cancer, such as the human papillomavirus that is responsible for most cases of cervical cancer, disrupt a cell's genome, thereby triggering out - of - control growth.

Although use of the human papillomavirus (HPV) vaccine, which helps prevent against cervical and other cancers, has increased in the past 5 years, HPV vaccination remains low with only 37.6 % of adolescent girls and 13.9 % of adolescent boys receiving vaccination.

(The much - publicized HPV cancer vaccine works in a more traditional style: It primes the immune system to fight off human papillomavirus, which can cause cervical cancer.)

«Human papillomavirus, or HPV, now causes the majority of tonsillar cancers in the United States and many western nations.

The human papillomavirus (HPV) spreads surprisingly quickly between two people in a new relationship, a new study finds.

Since the licensure of the quadrivalent human papillomavirus (qHPV) vaccine in 2006 and the later licensure of the bivalent HPV (bHPV) vaccine, more than 175 million doses have been distributed worldwide.

«In people chronically infected with hepatitis B or C, human papillomaviruses or other viruses known to cause cancer, radioimmunotherapy could potentially eliminate virus - infected cells before they're able to transform into cancer cells.»

Expanding human papillomavirus (HPV) vaccination programs to include males in Canada will help protect them against HPV - related cancers, according to an analysis published in CMAJ (Canadian Medical Association Journal).

They have become a valuable resource for biologists, enabling momentous scientific breakthroughs including the development of the polio vaccine the Nobel Prize winning studies defining the role of telomerase in aging, and research on the causative role of human papillomavirus (HPV) in some types of cervical cancer.

This shift has been traced to an increase in the human papillomavirus (HPV), the sexually transmitted infection that also causes cervical cancer.

Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States.

New research out of Queen's University shows early benefits from the human papillomavirus (HPV) vaccine in young girls.

In a Journal of Internal Medicine study of more than 3 million Danish and Swedish adult women, human papillomavirus (HPV) vaccination was not linked with 44 serious chronic diseases.

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various cancers, and a new study published online by JAMA Oncology estimates the overall prevalence of genital HPV infection in men ages 18 to 59.

The human papillomavirus (HPV) causes genital warts and has been found in more than 90 % of cervical tumors.

Papillomaviruses are a diverse group of DNA - based viruses that infect the skin and mucous membranes of humans and a variety of animals (replicating exclusively in keratinocytes).

When the vaccine against human papillomavirus was rolled out in the Netherlands in 2009, a surge of opposition and rumors about serious side effects took Coutinho and others by surprise.

Cosette Wheeler, PhD, at The University of New Mexico Comprehensive Cancer Center, led the research team and the efforts of the New Mexico Human Papillomavirus Pap Registry, the data source used in the study.

Human papillomavirus (HPV) is present in 99 percent of cervical cancers and is considered to be their cause.

Approximately 15 % of cancers diagnosed in 2012 were attributed to carcinogenic infections, including Helicobacter pylori, Human papillomavirus (HPV), Hepatitis B virus, Hepatitis C virus, and Epstein - Barr virus (3).

the vaccine for human papillomavirus (HPV) to behavioral problems in mice.

A vaccine for an extremely common sexually transmitted disease — human papillomavirus, or HPV — is making big strides in the war against cancer.

A retracted study linking the vaccine for human papillomavirus (HPV) to behavioral problems in mice has been republished by a different journal.

Smokers, drinkers, and people infected with the human papillomavirus (HPV) have the highest risk of developing head and neck cancer, which is the collective name for tumors found in the oral cavity, including the mouth, larynx, and pharynx.

Recent past honorees include Julian Adams of Infinity Pharmaceuticals, Alfred Goldberg of Harvard Medical School and Kenneth Anderson and Paul Richardson, both of Dana - Farber Cancer Institute, for the development of bortezomib, a drug that has altered the lives of hundreds of thousands of people with multiple myeloma; Alain Carpentier of Hôpital Européen Georges Pompidou in Paris and Robert S. Langer of MIT for innovations in bioengineering; and the work of Harald zur Hausen and Lutz Gissmann of the German Cancer Research Center on human papillomavirus (HPV) and cancer of the cervix, which was recognized by the WAFP prior to their receiving the Nobel Prize.

Identification of a human papillomavirus - associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.

Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes.

In prior studies, the researchers tested the virus on a variety of breast cancers that represent degrees of aggressiveness and on human papillomavirus - positive cervical cancer cells.